Ahlcon Parenterals India Ltd

What Ahlcon Parenterals India Ltd does

Ahlcon Parenterals (India) Limited is a pharmaceutical contract manufacturer founded in 1992 and headquartered in New Delhi, with manufacturing operations in Bhiwadi, Rajasthan. The company specializes in Large Volume Parenterals (LVP) and Small Volume Parenterals (SVP), utilizing aseptic Blow-Fill-Seal technology imported from Europe and the United States to produce sterile formulations under a cGMP-compliant, Zero Defect quality framework. Its product portfolio spans four core categories — infusion therapy solutions (maintenance fluids, antibiotics, antifungals, anti-infectives, diuretics, anti-pyretics), ophthalmic topical drops, inhalation nebules, and injectables (electrolyte solutions and local anesthetics) — collectively exceeding 200 million units of annual production capacity. The company also manufactures B. Braun-branded IV administration sets and automated infusion pumps as part of its medical device contract manufacturing scope.

The company's revenue model rests on B2B contract manufacturing (OEM supply) to pharmaceutical companies for both domestic Indian and export markets across CIS, Africa, GCC, Eastern Europe, and Southeast Asia, supplemented by medical device manufacturing for the B. Braun group. A secondary E-shop channel supports direct transactions with registered commercial users. Since its acquisition by B. Braun Medical (India) Pvt. Ltd. in 2012, Ahlcon has operated as a wholly-owned subsidiary within the B. Braun group, with quality practices and distribution reach augmented by group-level integration. The firm maintains ISO 9001:2015, ISO 14001, and ISO 45001 certifications, and operates with a lean organizational footprint of 51-100 employees, indicating a focused contract manufacturing operation rather than a diversified pharmaceutical enterprise.

Name

Ahlcon Parenterals India Ltd

Legal name

Ahlcon Parenterals (India) Limited

Website

https://ahlconindia.com

Company type

Private

Founded year

1992

Operating status

Operating

Headcount range

51–100 employees

Short description

Ahlcon Parenterals (India) Limited is a B. Braun-owned pharmaceutical contract manufacturer founded in 1992, producing sterile Large and Small Volume Parenterals (LVP and SVP) using imported aseptic Blow-Fill-Seal technology for leading pharmaceutical companies across domestic Indian and export markets spanning CIS, Africa, GCC, Eastern Europe, and Southeast Asia.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing (Sterile Parenterals)

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Parenteral & Injectable Packaging Components (Stoppers, Seals, Syringes, Cartridges) (IMALAIAE)

akta.pro secondary industries

Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

• Pharmaceutical contract manufacturing
• Sterile parenteral formulations
• Large volume parenterals
• Blow-fill-seal technology
• Infusion therapy products

Headquarters

HQ city

New Delhi

HQ country

India

HQ region

Asia

Offices4 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Contract Manufacturing: OEM supplier of Large Volume Parenterals (LVP) and Small Volume Parentals (SVP) to pharmaceutical companies for domestic and international markets. Provides manufacturing projects and customized products according to detailed specifications.
2. Medical Devices Contract Manufacturing: Contract manufacturing of customized medical devices, including IV administration sets and automated infusion pumps for B. Braun products.
3. E-commerce / E-shop Sales: Online ordering platform for registered commercial users (traders, self-employed, or employees of commercial enterprises) to purchase products directly.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Ahlcon Parenterals (India) Limited is a B. Braun group pharmaceutical contract manufacturer producing Large Volume Parenterals (LVP) and Small Volume Parenterals (SVP) — including infusion solutions, ophthalmic drops, inhalation nebules, and sterile injectables — using aseptic Blow-Fill-Seal technology at its cGMP-compliant Bhiwadi facility. The company also contract-manufactures B. Braun IV administration sets and automated infusion pumps, serving domestic pharmaceutical companies and international export markets (CIS, Africa, GCC, Eastern Europe, Southeast Asia).

Product overview

Ahlcon Parenterals (India) Ltd is a B. Braun group company and major pharmaceutical formulation manufacturer specializing in Large and Small Volume Parenterals (LVP and SVP). The company operates as an OEM supplier using European and U.S.-imported aseptic Blow-Fill-Seal Technology. The product portfolio consists of four main categories: (1) Infusion Therapy Products including maintenance fluids (Dextrose solutions, Sodium Chloride), volume replacement solutions (Ringer's Lactate, Hydroxyethyl starch), antibiotics (Ciprofloxacin, Levofloxacin, Moxifloxacin, Metronidazole), anti-infectives, antifungals (Fluconazole), diuretics (Mannitol), and anti-pyretics (Paracetamol); (2) Topical Drops (Ophthalmic Preparations) including antibiotic eye drops (Ciprofloxacin, Moxifloxacin, Tobramicin, Gentamicin, Norfloxacin), combination drops with steroids (antibiotics with Dexamethasone), anti-allergy drops, lubricants (Carboxy Methyl Cellulose), and analgesics (Diclofenac Sodium); (3) Inhalation Nebules including bronchodilators (Salbutamol, Salbutamol with Ipratropium) and corticosteroids (Budesonide Respiratory Suspension); (4) Injectables including electrolyte solutions, local anaesthetics (Lidocaine), and diluents. Additionally, Ahlcon manufactures B. Braun's IV Administration Sets and Automated Infusion Pumps. The company also offers pharmaceutical contract manufacturing services and customized medical devices.

Differentiator

Problem solved

Functional benefit

Products and services

• Infusion Therapy Products Comprehensive range of large and small volume parenteral formulations including maintenance fluids (Dextrose, Sodium Chloride), volume replacement solutions (Ringer's Lactate, Hydroxyethyl starch), anti-infectives, antibiotics (Ciprofloxacin, Levofloxacin, Moxifloxacin, Metronidazole, Linezolide), antifungals (Fluconazole), diuretics (Mannitol), and anti-pyretics (Paracetamol) administered intravenously for clinical therapies.
• Topical / Ophthalmic Drops Sterile ophthalmic preparations including antibiotic eye drops (Ciprofloxacin 0.3%, Moxifloxacin 0.5%, Tobramicin, Gentamicin, Norfloxacin), beta-blocker drops (Timolol 0.25%/0.5%) for glaucoma, combination drops with steroids, anti-allergy drops, lubricants (Carboxy Methyl Cellulose), and analgesics (Diclofenac Sodium) for conjunctival/eyelid application.
• Inhalation Nebules Sterile respiratory solutions including bronchodilators (Salbutamol, Salbutamol with Ipratropium) and corticosteroids (Budesonide Respiratory Suspension 0.5mg/2ml and 1mg/2ml) for nebulizer administration in the treatment of asthma, COPD, and laryngitis subglottica.
• Injectables Sterile, non-pyrogenic single-dose parenteral containers including diluents, local anaesthetics (Lidocaine HCl 0.5% and 1.0% for nerve blockade and epidural anaesthesia), and electrolyte solutions (Potassium Chloride BP 10%, Electrolyte M/P/G/E solutions) for clinical use.
• IV Administration Sets B. Braun IV administration sets contract-manufactured by Ahlcon that enable controlled transfer of infusion fluid to the patient's venous system for clinical infusion therapy.
• Automated Infusion Pumps B. Braun automated infusion systems contract-manufactured by Ahlcon for high-precision controlled delivery of drugs and infusion fluids to patients in clinical settings.
• Pharmaceutical Contract Manufacturing (OEM) Services Customized contract manufacturing of Large and Small Volume Parenterals (LVP and SVP) to detailed buyer specifications, including full regulatory, analytical, and logistical services for pharmaceutical companies in domestic and export markets (CIS, Africa, GCC, Eastern Europe, Southeast Asia). Also includes contract manufacturing of customized medical devices such as IV administration sets and automated infusion pumps for B. Braun products.

Quantifiable outcome

• Over 200 million units of parenterals delivered annually
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• B. Braun Medical (India) Pvt. Ltd.coreStrategic or Co-development Partner · 1 January 2012B. Braun Medical (India) Pvt. Ltd. acquired Ahlcon Parenterals (India) Limited in 2012. Ahlcon operates as a B. Braun group company with quality delivery enhanced through strengthening of Quality practices under B. Braun's guidance. B. Braun provides global commitment towards energy efficiency, climate protection, and health and safety standards.

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• Recipharm: European CDMO offering sterile fill-finish and parenteral manufacturing services for global pharma clients. Comparable to Ahlcon as a contract manufacturer specializing in aseptic parenteral production using BFS and similar technologies.
• Aenova Group: European CDMO with solid, semi-solid and aseptic liquid dosage form manufacturing including parenterals. Comparable to Ahlcon as a contract manufacturer offering sterile fill-finish services.
• Piramal Pharma Solutions: India-headquartered CDMO with sterile injectables and parenteral fill-finish capabilities serving global pharma customers. Highly comparable to Ahlcon as a domestic Indian contract manufacturer of parenteral formulations, though at significantly larger scale.

Regional players

• Syngene International: India-based CRO/CDMO serving global pharma with formulation development and manufacturing services. Comparable to Ahlcon as an India-headquartered contract services provider to multinational pharma customers, though with a different therapeutic mix.
• Neuland Laboratories: Indian CDMO specializing in APIs and finished dosage forms including injectables. Comparable to Ahlcon as a domestic Indian contract manufacturer serving global pharma with regulated manufacturing capability.

Broad incumbents

• Hospira (Pfizer): Now part of Pfizer, Hospira was the world's largest injectable pharmaceuticals business, with deep parenteral manufacturing capability across generic injectables and infusion therapies. Comparable to Ahlcon across the parenterals value chain.
• Baxter International: Global leader in IV solutions, parenteral nutrition, and injectable pharmaceuticals. Comparable as a global incumbent in the same parenteral and infusion therapy product categories Ahlcon serves.
• Aurobindo Pharma: Large Indian pharmaceutical manufacturer with a substantial sterile injectables and parenterals portfolio serving regulated and emerging markets. Comparable to Ahlcon as an India-based producer of LVPs/SVPs targeting similar export geographies.
• B. Braun Melsungen AG: Ahlcon's ultimate parent group, one of the world's largest infusion therapy and parenteral delivery companies. Ahlcon manufactures B. Braun IV sets and infusion pumps, making the parent the most directly relevant strategic counterparty.

Others

• West Pharmaceutical Services: Global supplier of primary packaging components and delivery systems for injectable drugs (stoppers, seals, syringes). Comparable to Ahlcon's Blow-Fill-Seal aseptic parenteral capability and IV administration set manufacturing through shared parenteral delivery ecosystem.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ahlconindia.com%2Fen.html
• LinkedInlinkedin.com/company/ahlcon-parenterals-india-ltd

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ahlcon Parenterals India Ltd